Archivos de Neurociencias is the official organ of the Instituto Nacional de Neurología y Neurocirugía.
It is an open access, quarterly, peer-reviewed journal that does not apply any fees for processing, editing or publishing. The journal is devoted to spreading high-quality scientific research in all Neuroscience fields. It accepts original articles, short articles, systematic reviews, and research protocols, among others.

 

Archivos de Neurociencias considers for publication research studies regarding clinical, experimental, translational, technological, social, and humanities perspectives of neurosciences, involving both central and peripheral nervous systems. This includes, but is not limited to, the following areas: psychiatry, neurology, neurosurgery, neurogenetics, neuropsychology, molecular biology, neurophysiology, neurochemistry, neuropharmacology, neuroimmunology, neurobiology, neuroendocrinology, veterinary neuroscience, and social neuroscience.

H-INDEX: 7
Days to first editorial decision (2023): 12
Rejection rate (2023): 35%
Scimago SJR (2022): 0.105
CiteScore (2022): 0.1
SNIP (2022): 0.053




Current Issue:

Vol.29 Num.4

October - December,
Volume 29, Number 4

Editorial:

Original articles:

Rodrigo Gómez-Rosiles, Felipe Chavelas-Ochoa, Renata Miranda-Echevarría

Tethered spinal cord syndrome secondary to posnatal repair of spina bifida vs. in utero

Mario Medina-Céspedes, Luis G. Jiménez-Herrera, Eugenia Cordero-García, Miguel Barboza-Elizondo

Analysis of the budgetary impact of ocrelizumab in people with multiple sclerosis

Daniela L.C. Delgado-Lara, Genaro G. Ortiz, Héctor A. González-Usigli, G. Viviana González-Enríquez, Efrain Chavarria-Avila, Blanca M. Torres-Mendoza

Melatonin administration showed no effect on depression and anxiety in Parkinson’s disease: pilot study

Review article:

Cesarina L. Torres-Vásquez, Diana P. Romero-Terán, Arturo Abundes-Corona, Amin Cervantes-Arriaga, Mayela Rodríguez-Violante, Ana J. Hernández-Medrano

A scoping review on experimental therapeutics for Parkinson’s disease: precision- and broad-targeted therapies

Synthesis of evidence:

Enrique García-Alfonso, Yanier Núñez-Figueredo

Mixed dementia: experimental animal models and treatments

Case reports:

Mitzi G. Márquez-Vargas, Ángel Escamilla-Ramírez, Gina González-Calderón, Juan C. López-Hernández, Javier Galnares-Olalde, Edwin S. Vargas-Cañas

Late onset inflammatory myopathy associated with anti-Ro52 antibodies without lung involvement. Case report

Manuel R. Barojas-Álvarez, Alma R. Martínez-Rosas

Long-COVID stigma in Mexican armed forces health services

Mareli Vázquez-Barreto, Julián Celedón-Suárez, Héctor M. Tapia-Hernández, Ulises Coffeen

Cannabinoid treatment for rapidly progressive dementia

Close